FDA Won't Pull Pfizer Alzheimer's Drug From Market
The U.S. Food and Drug Administration on Tuesday rejected a consumer advocacy group's bid to pull a Pfizer Inc. Alzheimer's drug over efficacy and safety concerns, saying the lack of drugs...To view the full article, register now.
Already a subscriber? Click here to view full article